UNSPSC 51172312: Edetate calcium disodium

This classification denotes a chelating agent with the molecular formula C10H12N2O8.CA.2NA.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 25IH6R4SGF. The term calcium disodium edetate hydrate is a Japanese Accepted Name designation. As of Q4 2014, EDETATE CALCIUM DISODIUM remains the US FDA Preferred Term for this commodity. Edetate calcium disodium bears US NLM identifiers UMLS ID C0006692 and NCI Concept Code C334. SMILES: C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+].

UNSPSC 51172312 Edetate calcium disodium is a Commodity code for a specific pharmaceutical chelating agent, but recent state and local solicitations tagged with this code do not reflect procurement of edetate calcium disodium itself. Instead, the opportunities show state and local bodies buying broad pharmaceutical and drug-testing services under a misaligned code classification. Collin County Community Supervision and Corrections Department solicited offender specimen collection and drug testing services—encompassing lab staffing, immunoassay screening, LC/MS/MS and GC/MS confirmation testing, and alternative methodologies including oral fluid and hair analysis—under RFP 2026-327, due July 23, 2026, with an estimated annual value of $600,000 over two years plus three optional one-year renewals. The Texas Health and Human Services Commission issued a market-intelligence RFI in April 2026 exploring direct-to-manufacturer prescription programs for state pharmacy benefits, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by Minnesota Department of Administration released an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers to state and local facilities in Minnesota and Oregon, due March 26, 2026. These three opportunities span criminal-justice drug testing, state pharmacy benefit management, and cooperative pharmaceutical supply—none directly aligned with edetate calcium disodium procurement.

Issuing bodies include county criminal-justice agencies, state health departments, and multistate cooperative purchasing organizations. Geographic activity centers on Texas (Collin County and HHS) and Minnesota (MMCAP). The code shows little relevant recent activity for the specific pharmaceutical product it nominally represents; the three solicitations appear to have been tagged with 51172312 as a catch-all for pharmaceutical-related work rather than as a procurement of edetate calcium disodium itself. Business development professionals tracking this code should verify whether the issuing bodies actually intend to buy edetate calcium disodium chelation therapy products or whether the code classification reflects administrative miscoding of broader pharmaceutical and testing services.